Skip to content

ICAAC: Moxifloxacin as effective as ethambutol in TB treatment

Premature to say atazanavir not linked to fat loss, says lipodystrophy expert

Pfizer releases further details of liver toxicity in maraviroc study

Ranbaxy announces new co-packaged triple ART combinations

Interleukin-2 has short-lived negative impact on quality of life

Tipranavir continues to show benefit in treatment-experienced patients after one year

TMC125 is safe and effective in patients with NNRTI resistance

New tablet formulation of Kaletra approved in US

Second company halts CCR5 inhibitor study in another blow to new drug class